Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Dyve Biosciences
Dyve develops novel therapeutics using proprietary science that leverages the skin as a portal for systemic delivery.
Sector
Subsector
Location
total rounds
total raised
AbCellera Biologics
AbCellera is a Vancouver-based company focused on antibody discovery and immune profiling.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
Demuris
Demuris is a drug discovery firm that aims to revolutionize the natural product drug pipeline.
Sector
Subsector
Location
Curve Therapeutics
Curve develops an innovative screening platform for drug discovery.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 29.12.2023. Their latest round Venture - Series Unknown
Bristol Myers Squibb
Bristol-Myers Squibb is a pharmaceuticals and nutritional products company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors6
Number of lead investors
Number of investors
IndieBio
IndieBio is a biotechnology and life science startup accelerator that focuses on solving global problems using biology.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Bristol Myers Squibb
Bristol-Myers Squibb is a pharmaceuticals and nutritional products company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
SOSV
SOSV is a global venture capital firm that supports early-stage startups.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Arvind Gupta
Arvind Gupta co-leads Mayfield’s Engineering Biology practice. He was the first investor in breakout bio companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite and Memphis Meats. As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world class adjunct partner board. He is now Venture Advisor at IndieBio. Arvind is the author of Decoding the World: A Roadmap for the Questioner, published by Twelve Books, a division of the Hachette Publishing Group. He was honored with the F50 Global Award for Impact in HealthTech Innovation. He is a frequent speaker at TechCrunch Disrupt, Slush, TedX and Future FoodTech. His work has been profiled in global media outlets such as Bloomberg News, Forbes, The Guardian UK, Neo.life, Nikkei News, Rotman, The Times of India, and CGTN in China. Arvind has been a guest lecturer at UCSF, MIT and Harvard and is a judge at the annual BIO conference startup stadium. Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. Arvind received his B.S. in Genetic Engineering from UCSB. He holds 8 patents. Arvind is married to an Icelander and has two daughters.
current job
organization founded
People
Founders2
Charly Chahwan
Charly Chahwan is the Co Founder, CSO at SyntheX.
current job
organization founded
Charly Chahwan
Maria Soloveychik
Maria Soloveychik and Charly Chahwan are working on curing untreatable cancer. They are disrupting the drug discovery cycle which typically takes $10m to $15m and upto 6 years. They have created compounds that have similar efficacy as other drugs and they were able to get to that stage in 2 months at the cost of $20,000 … I am going to let that sit with you. If that is not disruptive I am not sure what is. Maria Soloveychik is the CEO and co-founder of SyntheX Labs, a biotech company developing peptide therapeutics for cancer and other rare diseases. SyntheX labs was part of IndieBio batch #3 in 2016. They have successfully raised seed capital to move their vision forward. It was exciting to talk to Maria, she embodies everything that is inspiring about a founder.
current job
organization founded
Maria Soloveychik
Employee Profiles3
Maria Soloveychik
Chief Executive Officer & Co-Founder
Charly Chahwan
Co Founder & Chief Scientific Officer